Method Article

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

DOI:

10.3791/52333

June 17th, 2015

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The protocols describe two in vitro developmental toxicity test systems (UKK and UKN1) based on human embryonic stem cells and transcriptome studies. The test systems predict human developmental toxicity hazard, and may contribute to reduce animal studies, costs and the time required for chemical safety testing.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Efficient protocols to differentiate human pluripotent stem cells to various tissues in combination with -omics technologies opened up new horizons for in vitro toxicity testing of potential drugs. To provide a solid scientific basis for such assays, it will be important to gain quantitative information on the time course of development and on the underlying regulatory mechanisms by systems biology approaches. Two assays have therefore been tuned here for these requirements. In the UKK test system, human embryonic stem cells (hESC) (or other pluripotent cells) are left to spontaneously differentiate for 14 days in embryoid bodies, to allow generation of cells of all three germ layers. This system recapitulates key steps of early human embryonic development, and it can predict human-specific early embryonic toxicity/teratogenicity, if cells are exposed to chemicals during differentiation. The UKN1 test system is based on hESC differentiating to a population of neuroectodermal progenitor (NEP) cells for 6 days. This system recapitulates early neural development and predicts early developmental neurotoxicity and epigenetic changes triggered by chemicals. Both systems, in combination with transcriptome microarray studies, are suitable for identifying toxicity biomarkers. Moreover, they may be used in combination to generate input data for systems biology analysis. These test systems have advantages over the traditional toxicological studies requiring large amounts of animals. The test systems may contribute to a reduction of the costs for drug development and chemical safety evaluation. Their combination sheds light especially on compounds that may influence neurodevelopment specifically.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The ability of human embryonic stem cells (hESC) to differentiate into various types of cells opened up a new era of in vitro toxicity testing1, disease modelling and regenerative medicine2. The stem cells are endowed with the capacity to self-replicate, to keep their pluripotent state, and to differentiate into specialized cells3,4. The properties of hESC (capacity to differentiate to all major cell types) are also found in other human pluripotent stem cells, such as human induced pluripotent stem cells (hiPSC) or cells generated by nuclear transfer5. For instance, many different hESC lines have been differentiated....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The following protocol was performed using human Embryonic Stem Cell line (hESC) H9. This cell line was routinely cultured on mitotically inactivated mouse embryonic fibroblasts (MEFs) in hESC culture media supplemented with bFGF and then cultured in stem cell media on 6 cm Petri plates coated with basement membrane matrix such as matrigel, to get rid of MEFs. The H9 cells from >80% confluent plates were used for further passage. H9 cells cultured on basement membrane matrix plates were used for EBs formation. All procedures mentioned in the following protocol have been performed using standard methods for aseptic and good cell culture....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Methyl mercury exposure in UKK test system

The cytotoxicity assay was performed with H9 EBs to obtain an IC10 value (reduction of viability by 10%) for the cytotoxicity of methyl mercury (Figure 1). We also performed a microarray based (affymetrix platform) biomarker study. The H9 EBs have been exposed to methyl mercury (0.25 and 1 µM) for 14 days. On day 14, samples have been collected using TRIzol and RNA was isolated. Transcriptional profiling was performed using.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Traditional approaches to toxicological testing involve extensive animal studies thus making testing costly and time-consuming. Moreover, due to the interspecies differences the preclinical animal safety studies are not always valid to predict toxicity effects of potential drugs relevant for humans. Although non-human primates are most predictable, still strong ethical, and socioeconomical demands are rapidly raising by modern societies for developing sensitive and robust in vitro test system relevant t.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have nothing to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

We thank M. Kapitza, Margit Henry, Tamara Rotshteyn, Susan Rohani and Cornelia Böttinger for excellent technical support. This work was supported by grants from the German Research Foundation (RTG 1331) and the German Ministry for Research (BMBF).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
DMEM/F-12Life Technologies11320082Dulbecco's Modified Eagle Medium:Nutrient Mixture F-12
KOSRLife Technologies10828028Knockout Serum Replacement
GlutaMAXLife Technologies35050061GlutaMAX supplement
NEAALife Technologies11140050MEM Nonessential Amino Acids Solution
DPBSLife Technologies14190-0144Dulbecco's Phosphate-Buffered Saline, without calcium, without magnesium
mTeSR mediumStemcell Technologies5850
Pluronic F-127SigmaP2443-250G
V bottom plateVWR734-0483Plate,Microwell,V BTTM,96 Well,Sterile 1 * 50 ST
V bottom plate lidVWR634-0011Lid, Microtitre plates, Cond. Ring 1 * 50 ST
Pen/StrepLife Technologies15140-122Penicillin-Streptomycin, Liquid
Distilled WaterLife Technologies15230-089.Sterile Distilled Water
Human FGF-2 (bFGF)MilliporeGF003AF-100UGFibroblast Growth Factor basic, human recombinant, animal-free
Filter 0.22 μmMilliporeSCGPU02REStericup-GP, 0.22 μm, polyethersulfone, 250 ml, radio-sterilized
StemPro EZPassageTM DisposablteInvitrogen23181010
BD MatrigelTM, hESC qualified MatrixStemcell Technologies3542775 ml vial
DMSOSigmaD-2650
RNAlater Stabilization SolutionLife TechnologiesAM7020It stabilizes and protect the RNA integrity in unfrozen samples.
70 μm Cell StrainerBecton Dickinson352350Cell strainer with 70 μm Nylon mesh
35 μm Lid cell strainer, 5 ml tubeBecton Dickinson3522355 ml polystyrene round bottom test tube, with a cell strainer cap (35 μm)
50 ml sterile Polypropylene tubeGreiner Bio-One22726150 ml Polypropylene tube with conical bottom, Sterile
T75 flaskGreiner Bio-One658175CELLSTAR Filter Cap Cell Culture 75 cm2 Flasks
TRIzolLife Technologies10296010
96 well optical bottom platesThermo Scientific165305
CellTiter-BluePromegaG8081
AccutasePAAL11-007
ApotransferinSigma-AldrichT-2036
DispaseWorthington BiochemicalsLS002104
DorsomorphinTocris Bioscience3093
EDTARoth8043.2
FBSPAAA15-101
FGF-2R&D Systems233-FB
GelatineSigma-AldrichG1890-100G
GlucoseSigma-AldrichG7021-100G
GlutaMAXGibco Invitrogen35050-038
HEPESGibco Invitrogen15630-056
InsulinSigma-AldrichI-6634
Knockout DMEMGibco Invitrogen10829-018
MatrigelBD Biosciences354234
NogginR&D Systems719-NG
PBSBiochrom AGL1825
ProgesteronSigma-AldrichP7556
PutrescineSigma-AldrichP-5780
ROCK inhibitor Y-27632Tocris Biosciences1254
SB431542Tocris Biosciences1614
SDSBio-Rad161-0416
SeleniumSigma-AldrichS-5261
β-MercaptoethanolGibco Invitrogen31350-010
[header]
List of Kits
RNeasy Mini Kit (250)QIAGEN74106
GeneChip Hybridization, Wash, and Stain KitAffymetrix900721, 22, 23This kit provides all reagents required for hybridization wash and staining of microarrays.
Rnase-Free DNase SetQIAGEN79254
[header]
List of equipment
Inverted microscopeOlympusIX71
Genechip Hybridisation Oven - 645Affymetrix
Genechip Fluidics Station-450Affymetrix
Affymetrix Gene-Chip Scanner-3000-7 GAffymetrix
Spectramax M5Molecular Devices
 
 
 
[header]
List of softwares
Prism 4
Affymetrix GCOS
Partek Genomic Suite 6.25
Online tools for Functional annotation
DAVID
Onto-tools Intelligent Systems and Bioinformatics Laboratory

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Liu, W. W., Deng, Y. G., Liu, Y., Gong, W. R., Deng, W. B. Stem Cell Models for Drug Discovery and Toxicology Studies. Journal of Biochemical and Molecular Toxicology. 27 (1), 17-27 (2013).
  2. Zuba-Surma, E. K., Jozkowicz, A., Dulak, J. Stem Cells in Pharmaceut....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Human Pluripotent Stem CellsDevelopmental Toxicity AssaysEmbryoid Body FormationNeuroectodermal Progenitor DifferentiationTranscriptome Microarray AnalysisChemical Safety ScreeningSystems Biology Data GenerationEarly Embryonic DevelopmentNeural Development ToxicityToxicity Biomarker Identification

Related Articles